Intraosseaous access is the first practical alternative for delayed peripheral or central intravenous access in emergencies that involves the vascular device with the end of the intraosseous catheter placed into the bone matrix, and thus, making it a route for primary means of vascular access in critically injured patients. Medications are introduced in the human bone marrow by using intraosseous infusion to provide an entry point in systemic circulation. The devices used for these are called intraosseous infusion devices. Thus, the introduction of such advanced products in the market is expected to drive growth of the global intraosseous infusion devices market over the forecast period.
Market Dynamics
The key players in the medical devices industry are focusing on the development of technologically advanced equipment, instruments, and systems for various surgical procedures. Thus, introduction of such advanced products in the market is expected to drive growth of the global intraosseous infusion devices market over the forecast period. For instance, in June 2020, Resuscitation Committee approved emergency intraosseous (IO) cannulation for in-patients across Cardiff and Vale University Health Board. It will harmonise the education and clinical delivery of IO access. IO access has been included in recent Resuscitation Council U.K. (2010) adult Advanced Life Support (ALS) guidelines for cases in which intravenous access is difficult or unavailable.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook